Praziquantel is effective against all human schistosomes; Oxamniquine is effective only against S. mansoni; Metriphonate is effective only against S. haematobium.
Only Oxamniquine is available in the UK.
People across all age groups benefit significantly from treatment with praziquantel to cure infection, reduce worm burden, and reduce other schistosomiasis-related morbidities. The World Health Organization recommends praziquantel in all infected people regardless of age including adults, pregnant women after the first trimester, breastfeeding women, and preschool-aged children ≥2 years of age.
Reference
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.